First Time Loading...
G

Gentian Diagnostics ASA
OSE:GENT

Watchlist Manager
Gentian Diagnostics ASA
OSE:GENT
Watchlist
Price: 37.6 NOK -0.53% Market Closed
Updated: May 16, 2024
Section:
 

Intrinsic Value

Gentian Diagnostics ASA is a medical diagnostics company. [ Read More ]

The intrinsic value of one GENT stock under the Base Case scenario is 17.89 NOK. Compared to the current market price of 37.6 NOK, Gentian Diagnostics ASA is Overvalued by 52%.

Key Points:
GENT Intrinsic Value
Base Case
17.89 NOK
Overvaluation 52%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case
What is intrinsic value?

Valuation Backtest
Gentian Diagnostics ASA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling GENT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Gentian Diagnostics ASA

What unique competitive advantages
does Gentian Diagnostics ASA hold over its rivals?

What risks and challenges
does Gentian Diagnostics ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Gentian Diagnostics ASA.

Provide an overview of the primary business activities
of Gentian Diagnostics ASA.

What unique competitive advantages
does Gentian Diagnostics ASA hold over its rivals?

What risks and challenges
does Gentian Diagnostics ASA face in the near future?

Summarize the latest earnings call
of Gentian Diagnostics ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Gentian Diagnostics ASA.

Provide P/S
for Gentian Diagnostics ASA.

Provide P/E
for Gentian Diagnostics ASA.

Provide P/OCF
for Gentian Diagnostics ASA.

Provide P/FCFE
for Gentian Diagnostics ASA.

Provide P/B
for Gentian Diagnostics ASA.

Provide EV/S
for Gentian Diagnostics ASA.

Provide EV/GP
for Gentian Diagnostics ASA.

Provide EV/EBITDA
for Gentian Diagnostics ASA.

Provide EV/EBIT
for Gentian Diagnostics ASA.

Provide EV/OCF
for Gentian Diagnostics ASA.

Provide EV/FCFF
for Gentian Diagnostics ASA.

Provide EV/IC
for Gentian Diagnostics ASA.

Show me price targets
for Gentian Diagnostics ASA made by professional analysts.

What are the Revenue projections
for Gentian Diagnostics ASA?

How accurate were the past Revenue estimates
for Gentian Diagnostics ASA?

What are the Net Income projections
for Gentian Diagnostics ASA?

How accurate were the past Net Income estimates
for Gentian Diagnostics ASA?

What are the EPS projections
for Gentian Diagnostics ASA?

How accurate were the past EPS estimates
for Gentian Diagnostics ASA?

What are the EBIT projections
for Gentian Diagnostics ASA?

How accurate were the past EBIT estimates
for Gentian Diagnostics ASA?

Compare the revenue forecasts
for Gentian Diagnostics ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Gentian Diagnostics ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Gentian Diagnostics ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Gentian Diagnostics ASA compared to its peers.

Compare the P/E ratios
of Gentian Diagnostics ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Gentian Diagnostics ASA with its peers.

Analyze the financial leverage
of Gentian Diagnostics ASA compared to its main competitors.

Show all profitability ratios
for Gentian Diagnostics ASA.

Provide ROE
for Gentian Diagnostics ASA.

Provide ROA
for Gentian Diagnostics ASA.

Provide ROIC
for Gentian Diagnostics ASA.

Provide ROCE
for Gentian Diagnostics ASA.

Provide Gross Margin
for Gentian Diagnostics ASA.

Provide Operating Margin
for Gentian Diagnostics ASA.

Provide Net Margin
for Gentian Diagnostics ASA.

Provide FCF Margin
for Gentian Diagnostics ASA.

Show all solvency ratios
for Gentian Diagnostics ASA.

Provide D/E Ratio
for Gentian Diagnostics ASA.

Provide D/A Ratio
for Gentian Diagnostics ASA.

Provide Interest Coverage Ratio
for Gentian Diagnostics ASA.

Provide Altman Z-Score Ratio
for Gentian Diagnostics ASA.

Provide Quick Ratio
for Gentian Diagnostics ASA.

Provide Current Ratio
for Gentian Diagnostics ASA.

Provide Cash Ratio
for Gentian Diagnostics ASA.

What is the historical Revenue growth
over the last 5 years for Gentian Diagnostics ASA?

What is the historical Net Income growth
over the last 5 years for Gentian Diagnostics ASA?

What is the current Free Cash Flow
of Gentian Diagnostics ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Gentian Diagnostics ASA.

Popular Strategic Analysis Valuation Future Outlook Peer Analysis Profitability Solvency Financials
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM
Revenue
Operating Income
Net Income
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Balance Sheet Decomposition
Gentian Diagnostics ASA

181m
Assets
34.4m
Liabilities
181m
Assets
34.4m
Liabilities
Current Assets 141.7m
Cash & Short-Term Investments 87.6m
Receivables 17m
Other Current Assets 37.1m
Non-Current Assets 39.3m
Long-Term Investments 101k
PP&E 18m
Intangibles 21.2m
Current Liabilities 25.3m
Accounts Payable 3.7m
Other Current Liabilities 21.6m
Non-Current Liabilities 9.1m
Long-Term Debt 9m
Other Non-Current Liabilities 73k
Efficiency

Earnings Waterfall
Gentian Diagnostics ASA

Revenue
135.2m NOK
Cost of Revenue
-78.5m NOK
Gross Profit
56.6m NOK
Operating Expenses
-63.8m NOK
Operating Income
-7.2m NOK
Other Expenses
-3.5m NOK
Net Income
-10.6m NOK
Gross Margin
Operating Margin
Net Margin
FCF Margin
ROE
ROA
ROIC
ROCE

Free Cash Flow Analysis
Gentian Diagnostics ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

GENT Profitability Score
Profitability Due Diligence

Gentian Diagnostics ASA's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROIC is Increasing
Exceptional 1-Year Revenue Growth
32/100
Profitability
Score

Gentian Diagnostics ASA's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

GENT Solvency Score
Solvency Due Diligence

Gentian Diagnostics ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Gentian Diagnostics ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GENT Price Targets Summary
Gentian Diagnostics ASA

Wall Street analysts forecast GENT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GENT is 58.14 NOK with a low forecast of 57.57 NOK and a high forecast of 59.85 NOK.

GENT Lowest Forecast
Wall Street Target
57.57 NOK
53% Upside
GENT Average Forecast
Wall Street Target
58.14 NOK
55% Upside
GENT Highest Forecast
Wall Street Target
59.85 NOK
59% Upside
Lowest
Price Target
57.57 NOK
53% Upside
Average
Price Target
58.14 NOK
55% Upside
Highest
Price Target
59.85 NOK
59% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

GENT Price
Gentian Diagnostics ASA

1M 1M
+4%
6M 6M
-6%
1Y 1Y
-20%
3Y 3Y
-23%
5Y 5Y
-29%
10Y 10Y
+45%
Annual Price Range
37.6
52w Low
35.8
52w High
49
Price Metrics
Average Annual Return -1.54%
Standard Deviation of Annual Returns 33.66%
Max Drawdown -58%
Shares Statistics
Market Capitalization 579.9m NOK
Shares Outstanding 15 422 350
Percentage of Shares Shorted
N/A

GENT Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Gentian Diagnostics ASA

Country

Norway

Industry

Health Care

Market Cap

579.9m NOK

Dividend Yield

0%

Description

Gentian Diagnostics ASA is a medical diagnostics company. The company is headquartered in Moss, Ostfold. The company went IPO on 2016-12-14. The firm develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company’s product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The firm is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.

Contact

OSTFOLD
Moss
Bjornasveien 5
+4799339905
https://www.gentian.com/

IPO

2016-12-14

Employees

52

Officers

Chief Executive Officer
Dr. Hilja Ibert
CFO & COO
Mr. Njaal Kind
Chief Scientific Officer
Dr. Aleksandra Havelka
Chief Commercial Officer
Mr. Markus Jaquemar
Head of Innovation & Research
Dr. Ingo Curdt
Head of Product Development
Dr. Tom Nilsen

See Also

Summary
GENT intrinsic value, competitors valuation, and company profile.
DCF Valuation
GENT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GENT stock valuation using valuation multiples.
Wall Street Estimates
GENT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GENT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is the Intrinsic Value of one GENT stock?

The intrinsic value of one GENT stock under the Base Case scenario is 17.89 NOK.

Is GENT stock undervalued or overvalued?

Compared to the current market price of 37.6 NOK, Gentian Diagnostics ASA is Overvalued by 52%.

ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.